263 related articles for article (PubMed ID: 24718895)
1. FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion.
Bäumer D; East SZ; Tseu B; Zeman A; Hilton D; Talbot K; Ansorge O
Acta Neuropathol; 2014 Oct; 128(4):597-604. PubMed ID: 24718895
[TBL] [Abstract][Full Text] [Related]
2. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.
Van Damme P; Veldink JH; van Blitterswijk M; Corveleyn A; van Vught PW; Thijs V; Dubois B; Matthijs G; van den Berg LH; Robberecht W
Neurology; 2011 Jun; 76(24):2066-72. PubMed ID: 21562247
[TBL] [Abstract][Full Text] [Related]
3. Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2.
Tazen S; Figueroa K; Kwan JY; Goldman J; Hunt A; Sampson J; Gutmann L; Pulst SM; Mitsumoto H; Kuo SH
JAMA Neurol; 2013 Oct; 70(10):1302-4. PubMed ID: 23959108
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous ALS and SCA2 associated with an intermediate-length
Ghahremani Nezhad H; Franklin JP; Alix JJP; Moll T; Pattrick M; Cooper-Knock J; Shanmugarajah P; Beauchamp NJ; Hadjivissiliou M; Paling D; Mcdermott C; Shaw PJ; Jenkins TM
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):579-582. PubMed ID: 33284045
[TBL] [Abstract][Full Text] [Related]
5. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
Li PP; Sun X; Xia G; Arbez N; Paul S; Zhu S; Peng HB; Ross CA; Koeppen AH; Margolis RL; Pulst SM; Ashizawa T; Rudnicki DD
Ann Neurol; 2016 Oct; 80(4):600-15. PubMed ID: 27531668
[TBL] [Abstract][Full Text] [Related]
6. ALS-associated genes in SCA2 mouse spinal cord transcriptomes.
Scoles DR; Dansithong W; Pflieger LT; Paul S; Gandelman M; Figueroa KP; Rigo F; Bennett CF; Pulst SM
Hum Mol Genet; 2020 Jun; 29(10):1658-1672. PubMed ID: 32307524
[TBL] [Abstract][Full Text] [Related]
7. Common origin of pure and interrupted repeat expansions in spinocerebellar ataxia type 2 (SCA2).
Ramos EM; Martins S; Alonso I; Emmel VE; Saraiva-Pereira ML; Jardim LB; Coutinho P; Sequeiros J; Silveira I
Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):524-531. PubMed ID: 19676102
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics DNA methylation in the core ataxin-2 gene promoter: novel physiological and pathological implications.
Laffita-Mesa JM; Bauer PO; Kourí V; Peña Serrano L; Roskams J; Almaguer Gotay D; Montes Brown JC; Martínez Rodríguez PA; González-Zaldívar Y; Almaguer Mederos L; Cuello-Almarales D; Aguiar Santiago J
Hum Genet; 2012 Apr; 131(4):625-38. PubMed ID: 22037902
[TBL] [Abstract][Full Text] [Related]
9. Model organisms reveal insight into human neurodegenerative disease: ataxin-2 intermediate-length polyglutamine expansions are a risk factor for ALS.
Bonini NM; Gitler AD
J Mol Neurosci; 2011 Nov; 45(3):676-83. PubMed ID: 21660502
[TBL] [Abstract][Full Text] [Related]
10. ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis.
Liu X; Lu M; Tang L; Zhang N; Chui D; Fan D
Neurobiol Aging; 2013 Sep; 34(9):2236.e5-8. PubMed ID: 23635656
[TBL] [Abstract][Full Text] [Related]
11. A case of amyotrophic lateral sclerosis with intermediate ATXN-1 CAG repeat expansion in a large family with spinocerebellar ataxia type 1.
Spataro R; La Bella V
J Neurol; 2014 Jul; 261(7):1442-3. PubMed ID: 24916831
[No Abstract] [Full Text] [Related]
12. Linkage analysis and whole-exome sequencing exclude extra mutations responsible for the parkinsonian phenotype of spinocerebellar ataxia-2.
Wang C; Xu Y; Feng X; Ma J; Xie S; Zhang Y; Tang BS; Chan P
Neurobiol Aging; 2015 Jan; 36(1):545.e1-7. PubMed ID: 25189117
[TBL] [Abstract][Full Text] [Related]
13. Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts.
Van Langenhove T; van der Zee J; Engelborghs S; Vandenberghe R; Santens P; Van den Broeck M; Mattheijssens M; Peeters K; Nuytten D; Cras P; De Deyn PP; De Jonghe P; Cruts M; Van Broeckhoven C
Neurobiol Aging; 2012 May; 33(5):1004.e17-20. PubMed ID: 22035589
[TBL] [Abstract][Full Text] [Related]
14. PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats.
Yu Z; Zhu Y; Chen-Plotkin AS; Clay-Falcone D; McCluskey L; Elman L; Kalb RG; Trojanowski JQ; Lee VM; Van Deerlin VM; Gitler AD; Bonini NM
PLoS One; 2011 Mar; 6(3):e17951. PubMed ID: 21479228
[TBL] [Abstract][Full Text] [Related]
15. Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions.
Highley JR; Lorente Pons A; Cooper-Knock J; Wharton SB; Ince PG; Shaw PJ; Wood J; Kirby J
Neuropathol Appl Neurobiol; 2016 Jun; 42(4):377-89. PubMed ID: 26095883
[TBL] [Abstract][Full Text] [Related]
16. Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions.
Hart MP; Brettschneider J; Lee VM; Trojanowski JQ; Gitler AD
Acta Neuropathol; 2012 Aug; 124(2):221-30. PubMed ID: 22526021
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of pathogenic ataxin-2 in Drosophila shows dependence on a pure CAG repeat sequence.
McGurk L; Rifai OM; Shcherbakova O; Perlegos AE; Byrns CN; Carranza FR; Zhou HW; Kim HJ; Zhu Y; Bonini NM
Hum Mol Genet; 2021 Sep; 30(19):1797-1810. PubMed ID: 34077532
[TBL] [Abstract][Full Text] [Related]
18. ATXN-2 CAG repeat expansions are interrupted in ALS patients.
Corrado L; Mazzini L; Oggioni GD; Luciano B; Godi M; Brusco A; D'Alfonso S
Hum Genet; 2011 Oct; 130(4):575-80. PubMed ID: 21537950
[TBL] [Abstract][Full Text] [Related]
19. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism.
Kim JM; Hong S; Kim GP; Choi YJ; Kim YK; Park SS; Kim SE; Jeon BS
Arch Neurol; 2007 Oct; 64(10):1510-8. PubMed ID: 17923635
[TBL] [Abstract][Full Text] [Related]
20. Intracellular dynamics of Ataxin-2 in the human brains with normal and frontotemporal lobar degeneration with TDP-43 inclusions.
Watanabe R; Higashi S; Nonaka T; Kawakami I; Oshima K; Niizato K; Akiyama H; Yoshida M; Hasegawa M; Arai T
Acta Neuropathol Commun; 2020 Oct; 8(1):176. PubMed ID: 33115537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
